Vimarsana
Biggest News Aggregation in the World

Page 3 - Human Servs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Servs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Servs Today - Breaking & Trending Today

Two Recent Federal Court Cases Tackle Three Critical Components of the Anti-Kickback Statute | Stevens & Lee - Vimarsana News

Two Recent Federal Court Cases Tackle Three Critical Components of the Anti-Kickback Statute | Stevens & Lee

Two recently decided federal court cases hone in on the proper interpretation and application of three critical components of the Anti-Kickback Statute (“AKS”), namely: •the...

Congress Urges FTC Scrutiny Of The Life Sciences Industry: Will This Be A New Chapter In The Administration's Drug Pricing Playbook? - Life Sciences, Biotechnology & Nanotechnology - Vimarsana News

Congress Urges FTC Scrutiny Of The Life Sciences Industry: Will This Be A New Chapter In The Administration's Drug Pricing Playbook? - Life Sciences, Biotechnology & Nanotechnology

On February 13, 2023, U.S. Senate Majority Whip Dick Durbin (D-IL), Chair of the Senate Judiciary Committee, sent a letter to the Antitrust Division of the Department of Justice...

Source: mondaq.com
Congress Urges FTC Scrutiny of the Life Sciences Industry: Will This Be a New Chapter in the Administration's Drug Pricing Playbook? | Akin Gump Strauss Hauer & Feld LLP - Vimarsana News

Congress Urges FTC Scrutiny of the Life Sciences Industry: Will This Be a New Chapter in the Administration's Drug Pricing Playbook? | Akin Gump Strauss Hauer & Feld LLP

On February 13, 2023, U.S. Senate Majority Whip Dick Durbin (D-IL), Chair of the Senate Judiciary Committee, sent a letter to the Antitrust Division of the Department of Justice (DOJ)...

Pharma Investment Trend Report: What We're Watching in 2023 | King & Spalding - Vimarsana News

Pharma Investment Trend Report: What We're Watching in 2023 | King & Spalding

2022 was a big year for the pharmaceutical and biotechnology sectors. Novel technologies emerged at a rapid clip. The Food and Drug Administration (“FDA” or the “Agency”) approved over...

Key Health Care Issues to Track in 2023 in the Carolinas | Nexsen Pruet, PLLC - Vimarsana News

Key Health Care Issues to Track in 2023 in the Carolinas | Nexsen Pruet, PLLC

Co-authored by: Garrett Reinhart, Law Clerk As 2023 begins, we are tracking several key legal and regulatory issues that are sure to impact the health care industry in North and South...